Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| 제품번호 | 종 | 제품 설명 | 구조 | 순도 | 특징 |
|---|---|---|---|---|---|
| BC1-H513a | Human | Human Bcl-x / BCL2L1 Protein, GST Tag |  |
|
|
| BC1-H5120 | Human | Human Bcl-x / BCL2L1 Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Gossypol acetic acid/Potassium Chloride/Vitamin B1/Vitamin B6 | Approved | Mainland China | Uterine Hemorrhage; Uterine Neoplasms; Endometriosis | Xi'An Beifang Medicine Co Ltd | 1988-01-01 | Endometriosis; Uterine Hemorrhage; Uterine Neoplasms | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| UBX-1325 | UBX-1325 | Unity Biotechnology Inc, Ascentage Pharma Group International | Details | ||
| DT-2216 | DT-2216 | Dialectic Therapeutics Inc, University Of Florida | Details | ||
| LP-118 | LP-118 | Phase 1 Clinical | Guangzhou Lupeng Pharmaceutical Co Ltd, Newave Pharmaceutical Inc | Lymphoma, B-Cell; Solid tumours; Leukemia; Bone Marrow Neoplasms; Neoplasms; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Leukemia, Prolymphocytic, T-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
| AZD-0466 | AZD-0466 | Phase 2 Clinical | Astrazeneca Pharmaceutical Co Ltd | Hematologic Neoplasms; Solid tumours; Neoplasms; Multiple Myeloma; Lymphoma, Non-Hodgkin; Lymphoma | Details |
| R-(-)-gossypol acetic acid | AT-101; BL-193; TW-37 | Phase 2 Clinical | University Of Michigan, Jiangsu Yasheng Pharmaceutical Development Co Ltd | Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Waldenstrom Macroglobulinemia; Burkitt Lymphoma; Lymphoma, T-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Laryngeal Neoplasms; Gliosarcoma; Prostatic Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Brain Neoplasms; Lymphoma, Follicular; Lymphoma, B-Cell, Marginal Zone; Central Nervous System Neoplasms; Adrenocortical Carcinoma; Multiple Myeloma; Small Cell Lung Carcinoma; Glioblastoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphomatoid Granulomatosis; Leukemia, Lymphoid; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Solid tumours; Lymphoma, T-Cell, Peripheral | Details |
| Pelcitoclax | BM-1252; APG-1252 | Phase 2 Clinical | Jiangsu Yasheng Pharmaceutical Development Co Ltd | Solid tumours; Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lymphoma, Extranodal NK-T-Cell; Primary Myelofibrosis; Lymphoma, Non-Hodgkin; Carcinoma, Non-Small-Cell Lung | Details |
This web search service is supported by Google Inc.
A-Z
